Published in:
Open Access
01-12-2015 | Oral presentation
O059. Predictors of response to botulinum toxin for the treatment of chronic migraine: data from a Headache Center
Authors:
Raffaele Ornello, Serena Vittoria Lisi, Diana Degan, Cindy Tiseo, Francesca Pistoia, Antonio Carolei, Simona Sacco
Published in:
The Journal of Headache and Pain
|
Special Issue 1/2015
Login to get access
Excerpt
Chronic migraine (CM) is a disabling type of primary headache for which treatment with botulinum toxin type A (BoNT-A) has proved to be effective and safe in reducing headache days and headache-related disability. However, little is known about factors influencing the response to BoNT-A. We aimed to assess which baseline factors predicted a favorable response to BoNT-A in a sample of patients with CM. …